Submit Paper

Article Processing Fee

Pay Online

           

Crossref logo

  DOI Prefix   10.20431


 

ARC Journal of Nutrition and Growth
Volume-4 Issue-1, 2018, Page No: 14-17

Argemone ochroleuca: Biology, Pharmacological Potential and Perspectives

Torres-Gonalez Omar Ricardo1,Sanchez-Hernandez Ivan Moises1,Barragan-Alvarez Carla Patricia1,Flores-Fernandez Jose Miguel2,Padilla-Camberos Eduardo1*

1.Center for Research and Assistance in Technology and Design of the State of Jalisco.
2.Tecnológico de Estudios Superiores de Villa Guerrero.

Citation : Torres-Gonalez Omar Ricardo,et.al, "Argemone ochroleuca: Biology, Pharmacological Potential and Perspectives" ARC Journal of Nutrition and Growth . 2018; 4(1) : 14-17.

Copyright : © 2018 Authors. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Abstract:

Argemone ochroleuca is a native Mexican plant and now is widely distributed in tropical and subtropical regions of the world. It has a wide type of applications in traditional medicine. The plant contains alkaloids as the main active ingredients. Currently, research studies have begun to demonstrate their biological activity both for use in agriculture and in pharmacological applications.


Keywords: Argemone, Alkaloids, Extracts, Biological Activity,Nutrition and Growth


1. Introduction


The identification, collection and characterization of secondary metabolites of plants have been crucial in the search for compounds with biological activity capable of playing an important role in the prevention and treatment of diseases[1].

The papaveraceae family consists of annual or perennial herbaceous plants; they can grow in sunny and open environments. This group of plants is composed of approximately 45 genera with more than 400 species commonly distributed in different points of the Northern Hemisphere[2]. Papaveraceae family is included phylogenetically in a group known as "psychoactive families" because of it includes representative plants like Papaver somniferum L., “adormidera”; alkaloids such as morphine and heroin have been extracted from them, on the other hand these plants can be cultivated as ornamental plants[3].

Another representative group of the family is the genus Argemone, it is constituted mainly by herbaceous, and they can be annual or perennial plants composed of more than 30 species distributed in tropical regions of America, however Argemone mexicana L. and Argemone ochroleuca have been introduced in other parts of the world2. In Mexico they are commonly known as “chicalote”, “cardo santo” and as “falsa amapola”[4]. The origin of the word Argemone derives from the word "argema" which means "catarata del ojo" since formerly the juice of the vegetative part was used in the treatment for such a condition[5].

Recently numerous findings have been reported about biological activity of vegetative parts extracts from these plants like leaf, root, seed, flower, and latex[6]. In the present work, we will address the biology, pharmacological potential and perspectives of A. ochroleuca.

1.1. Biology of Argemone ochroleuca
A. ochroleuca is a hybrid allotetraploid species[7]; itblooms from November to June and commonly colonizes highly disturbed sites such as agro-crops, roadsides, railways and abandoned lots. Its phenotype shows stems and leaves that are provided with straight spines and yellow latex. The flowers are solitary and present hermaphroditism, their structure has three sepals and shown 4-6 petals of whitish color, it is provided with 40-75 stamens with syncarpic gynoecium and discoid stigma, besides it has tricolpate pollen grains and reticulated aspect; the fruit is a prickly berry2. It is considered a weed capable of adapting and even displacing the native flora present[8].

The specie A. ochroleuca has been frequently confused with A. mexicana by their close biological relationship, because they share similarity phenotypic[9]. In 1958, Ownbey suggested that A. mexicana played a very important role in the evolution of A. ochroleuca through the process of autopolyploidy[10]. One main biochemical characteristic of the genus is the presence of phytochemicals of great pharmacological importance, for example the alkaloids like Isoquinolines, from where compounds as Alocryptopine, Protopine and Berberine have been isolated and characterized[11]. The isolated alkaloids of A. mexicana and A. ochroleuca are listed in Table1.




1.2. Traditional use of Argemone ochroleuca in Mesoamerican culture
The “chicalote” is a plant that was used in the pre-Columbian culture of Mesoamerican peoples as an aid in the treatment of ocular, dermatological, respiratory, and diabetes problems. The first reference corresponds to the Florentine Codex of the sixteenth century, which relates in detail the use of latex to relieve eye pain; more over the naturalist Juan de Esteyneffer, at the beginning of the eighteenth century referred it in a medical compilation as a purgative remedy.

In the 20th century, the National Medical Institute indicates the following uses: antiescabietic, to treat dental problems, wound healing, and as regenerative, against dermatosis, and eye problems. Other contemporary researchers such as Alfonso Herrera, and Maximino Martínez pointed out that the flowers, leaves, and juice of the plant are used in some diseases of the eyes and other activities as anticonvulsant, antidiarrheal, antispasmodic, antitussive, cathartic potential, to treat corneal spots, joint diseases, hypnotic, narcotic, and analgesic[14].

1.3. Scientific biological activity of Argemone ochroleuca
Although most of the scientific evidence is oriented to the biological activity of A.mexicana, there are some reports that refer to the use of the products obtained from A. ochroleuca, and are shown in table2.




The following is described according to the date of appearance in the scientific literature: A study showed the relaxant activity of the dichloromethane extract using the aerial parts in smooth muscle of guinea pigs; they obtained an IC50 value of 118,50 ± 3,91 μM and identifyed the presence of the compound Berberine as an active principle15. Alamri, and Moustafa in 201016 reported the antimicrobial activity of crude, and diluted latex using the plate diffusion method on strains such as Bacillus subtilis, Enterobacter aerogenes, Micrococcus luteus, Escherichia coli, and Staphylococcus aureus, showing their potential at the minimum inhibitory concentration (MIC) of 100μL / mL[16]. The research team showed too the antifungal activity of crude latex against 4 candida species isolated from patients (Candida albicans, Candida glabrata, Candida krusei and Candida tropicalis) and against 6 species of phytopathogenic fungi (Alternaria alternante, Drechslera halodes, Fusarium oxysporum, Macrophomina phaseolina, Pythium ultimum, and Rhizoctoina solani). They made the hexane extract of the latex, and analyzed by gas chromatography-mass spectrophotometry that revealed the presence of diethyl phthalate (81,57%), compounds of 6-nitro-imidazo (1,2-a) pyridine (8,833%), cyclohexasiloxane, dodecamethyl (5,607%), molecules of 4- (2,2-dimethyl-6-methylenecyclohexylidene)-3- methylbutan-2-one (2,410%) and cycloheptasiloxane, tetradecamethyl (1,574%)[17].

Reyes et al18 showed the antimicrobial activity of extracts of hexane, ethyl acetate, and methanol from aerial parts of A. ochroleuca. The antimicrobial activity was evaluated in thirteen bacterial, and nine fungal strains. Only methanol extract showed antimicrobial activity, strains of S. aureus (MIC = 125 μg / mL) and C. neoformans (MIC = 500 μg / mL) were the most sensitive to treatment. The research team identified and isolated the alkaloid Berberine present in the methanolic extract[18].

Martínez et al20 showed that the ethanolic extract (15 and 30%) inhibits the feeding and larval development of the “gusano cogollero” Spodoptera frugiperda. Finally, in 2017, Basharat observed possible allelopathic effects of the aqueous extract of A. ochroleuca on grasslands and farmland with species of wild plants native from Arabia: (Farsetia aegyptia and Salvia aegyptiaca L.) and plants used for forage (Hordeum vulgare L. and Medicago sativa L.) exhibiting sufficient allelopathic potential[20].

Although there are reports that describe the importance of the compounds identified in A. ochroleuca, the number of findings that support the study of A. mexicana (218 citations) exceeds the articles that analyze A.ochroleuca (20 citations). Both species are native to the Americas, however most of the reports found in the literature belong to research groups from the Asian continent, where these species were introduced. Al-Shanawany in 1996 mentioned that the indiscriminate use of A. mexicana, and A. ochroleuca in traditional Saudi medicine is due to the fact that they do not have significant morphological differences. Therefore, it is very important to update the taxonomic studies of the genus as well as to know the methods of identification that the researchers use to define the species in pharmacological studies.


References


  1. Srivastava N., Singh Chauhan A. 2012. Isolation, and Characterization of Some Phytochemicals from Indian Traditional Plants. Hindawi Publishing Corporation Biotechnology Research International. 8 pp.
  2. Rendowski G.C. 1991. Flora del Bajío y de regiones adyacentes: “Papaveraceae” / por Graciela Calderón de Rzedowski. Fasc. 1. Instituto de Ecología, A. C. Centro Regional del Bajío. Pátzcuaro, Michoacán, Mexico.
  3. Alrashedy, N. A., Molina, J. 2016. The ethnobotany of psychoactive plant use: a phylogenetic perspective. PeerJ, 4, e2546.
  4. Sharanappa R., Vidyasagar G. 2014. Plant profile, phytochemistry and pharmacology of Argemonemexicana Linn. A review. Int. Journal of Pharmacy and Pharmaceutical Sciences. (6)7.
  5. Westhuizen L., Mpedi P. 2011. The initiation of a biological control programme against Argemone mexicana L. and Argemone ochroleuca sweet subsp. ochroleuca (Papaveraceae) in South Africa. African Entomology 19(SP):223-229.
  6. Brahmachari G., Gorai D., Roy R. 2013. Argemone mexicana: Chemical and pharmacological aspects. Brazilian Journal of Pharmacognosy 23(3): 559-575.
  7. Malik C., Grover I. 1973. The genus Argemone. Theoretical and applied genetics. 43: 329-334
  8. Amare S. et al. 2016. Assessment of the Invasive Alien Plant Species Argemone ochroleuca in North Gondar and West Gojam Zones, Amhara Region, Ethiopia. International Journal of Natural Resource Ecology and Management. Vol. 1, No. 3, 2016, pp. 107-114.
  9. Haisova, K., Slavik, J. 1973. “On alkaloids from Argemone ochroleuca Sweet ". Collect. Czech. Chem. Commun., 38, 2307-2312.
  10. Own-bey G. 1958. Monograph of the genus Argemone for North America and West Indias. Memoirs of the Tor. Bot. Club. 1, t-159.
  11. Haisova, K., Slavik, J. 1975. "On the minor alkaloids from Argemone mexicana L.” Collect. Czech. Chem. Commun., 40, 1576-1578
  12. Hussain, S. F., Nakkady, S., Khan, L., Shamma, M. 1983. "Oxhydrastinine, an Isoquinoline alkaloid from the Papaveraceae". Phytochemistry, 22, 319-320
  13. Fletcher, M., Takken, G., Blaney, B., Alberts, V. 1993. "Isoquinoline alkaloids and keto-faffy acids of Argemone ochroleuca and A. mexicana (Mexican poppy) seed". Aust. J. Agric. Res. 44, 265-275.
  14. Atlas de plantas de la medicina tradicional mexicana: El chicalote. Rescatado del sitio: http://www.medicinatradicionalmexicana.unam .mx; el 12 de enero del 2018.
  15. Sánchez M., Castillo C., Navarrete A. 2008. Relaxant action mechanism of berberine identified as the active principle of Argemone ochroleuca Sweet in guinea-pig tracheal smooth muscle. Journal of Pharmacy and Pharmacology. Volume 60. Issue 2, Pages 229-236.
  16. Alamri S., Moustafa M. 2010. Antibacterial activity of the latex of Argemone ochroleuca Sweet. Saudi med J. Vol. 31 (11).
  17. Reyes F. et al. 2011. Antimicrobial activity of Argemone ochroleuca Sweet (Chicalote). Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas 10 (2): 139 – 146.
  18. Moustafa M., Alamri S., Taha T., Alrumman S. 2013. In vitro antifungal activity of Argemone ochroleuca Sweet latex against some pathogenic fungi. African Journal of Biotechnology Vol. 12(10), pp. 1132-1137.
  19. Martínez A. et al. 2017. Effects of Ethanolic extracts of Argemone ochroleuca (Papaveraceae) on the Food Consumption and Development of Spodoptera frugiperda (Lepidoptera: Noctuidae). Florida Entomological Society.100 (2):339-345.
  20. Al-Shanawany, M. A. A. 1996. “Plants used in Saudi folk medicine ", King Abdul-Aziz City for Science and Technology, Riyadh, 15.